High ROIC Stocks
JNJ is currently part of our High ROIC Stocks screen, indicating it generates strong returns on invested capital.
JOHNSON & JOHNSON (JNJ) Stock Price & Overview
NYSE:JNJ • US4781601046
Current stock price
227.5 USD
-3.15 (-1.37%)
At close:
227.48 USD
-0.02 (-0.01%)
After Hours:
The current stock price of JNJ is 227.5 USD. Today JNJ is down by -1.37%. In the past month the price decreased by -4.91%. In the past year, price increased by 47.17%.
JNJ Key Statistics
52-Week Range146.115 - 251.71
Current JNJ stock price positioned within its 52-week range.
1-Month Range223.775 - 247.21
Current JNJ stock price positioned within its 1-month range.
- Market Cap
- 547.959B
- P/E
- 21.20
- Fwd P/E
- 17.93
- EPS (TTM)
- 10.73
- Dividend Yield
- 2.37%
JNJ Stock Performance
Today
-1.37%
1 Week
-2.85%
1 Month
-4.91%
3 Months
+3.34%
Longer-term
6 Months +19.49%
1 Year +47.17%
2 Years +57.34%
3 Years +38.97%
5 Years +39.80%
10 Years +102.98%
JNJ Stock Chart
JNJ Stock Screens
JNJ currently appears in the following ChartMill screener lists.
Best Dividend Stocks
JNJ is currently part of our Best Dividend Stocks screen, indicating it pays a high and sustainable dividend.
Safe Dividend Stocks
JNJ occurs in our Safe Dividends Stock Screen, indicating it has a high and sustainable dividend, while being financially healthy
Dividend Growth Stocks
JNJ is part of our Dividend Growth Stocks screen, indicating it has a reliable dividend with grows strongly
JNJ Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to JNJ. When comparing the yearly performance of all stocks, JNJ is one of the better performing stocks in the market, outperforming 80.27% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
JNJ Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to JNJ. While JNJ has a great profitability rating, there are some minor concerns on its financial health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
JNJ Earnings
On April 14, 2026 JNJ reported an EPS of 2.7 and a revenue of 24.06B. The company beat EPS expectations (0.32% surprise) and beat revenue expectations (0.82% surprise).
Next Earnings DateJul 14, 2026
Last Earnings DateApr 14, 2026
PeriodQ1 / 2026
EPS Reported$2.70
Revenue Reported24.062B
EPS Surprise 0.32%
Revenue Surprise 0.82%
JNJ Forecast & Estimates
32 analysts have analysed JNJ and the average price target is 244.99 USD. This implies a price increase of 7.69% is expected in the next year compared to the current price of 227.5.
For the next year, analysts expect an EPS growth of 7.91% and a revenue growth 7.43% for JNJ
Analysts
Analysts76.25
Price Target244.99 (7.69%)
EPS Next Y7.91%
Revenue Next Year7.43%
JNJ Groups
Sector & Classification
Sector
Health Care Sub-Industry
Pharmaceuticals JNJ Financial Highlights
Over the last trailing twelve months JNJ reported a non-GAAP Earnings per Share(EPS) of 10.73. The EPS increased by 6.77% compared to the year before.
Income Statements
Revenue(TTM)96.36B
Net Income(TTM)26.80B
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 28.46% | ||
| ROA | 13.46% | ||
| ROE | 32.87% | ||
| Debt/Equity | 0.56 |
Chartmill High Growth Momentum
EPS Q2Q%-2.53%
Sales Q2Q%9.91%
EPS 1Y (TTM)6.77%
Revenue 1Y (TTM)7.87%
JNJ Ownership
Ownership
Inst Owners75.61%
Shares2.41B
Float2.41B
Ins Owners0.04%
Short Float %0.93%
Short Ratio2.67
JNJ Latest News, Press Relases and Analysis
JNJ Competitors/Peers
The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 25.28 | 867.014B | ||
| MRK | MERCK & CO. INC. | 21.98 | 283.098B | ||
| PFE | PFIZER INC | 9.03 | 151.709B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.27 | 120.503B | ||
| ZTS | ZOETIS INC | 16.52 | 48.806B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.56 | 28.639B | ||
| VTRS | VIATRIS INC | 5.85 | 17.175B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.62 | 11.181B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 9.346B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.169B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 6.097B | ||
| CORT | CORCEPT THERAPEUTICS INC | 84.88 | 4.795B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About JNJ
Company Profile
The company is headquartered in New Brunswick, New Jersey and currently employs 138,200 full-time employees.
Company Info
IPO: 1944-09-25
JOHNSON & JOHNSON
One Johnson & Johnson Plaza
New Brunswick NEW JERSEY 08933 US
CEO: A. Gorsky
Employees: 138200
Phone: 17325242455
JOHNSON & JOHNSON / JNJ FAQ
Can you describe the business of JOHNSON & JOHNSON?
The company is headquartered in New Brunswick, New Jersey and currently employs 138,200 full-time employees.
What is the stock price of JOHNSON & JOHNSON today?
The current stock price of JNJ is 227.5 USD. The price decreased by -1.37% in the last trading session.
Does JOHNSON & JOHNSON pay dividends?
JOHNSON & JOHNSON (JNJ) has a dividend yield of 2.37%. The yearly dividend amount is currently 5.14.
What is the ChartMill technical and fundamental rating of JNJ stock?
JNJ has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
How is the market expecting JNJ stock to perform?
32 analysts have analysed JNJ and the average price target is 244.99 USD. This implies a price increase of 7.69% is expected in the next year compared to the current price of 227.5.
Can you provide the upcoming dividend date for JOHNSON & JOHNSON?
The next ex-dividend date for JOHNSON & JOHNSON (JNJ) is May 26, 2026.
How many employees does JOHNSON & JOHNSON have?
JOHNSON & JOHNSON (JNJ) currently has 138200 employees.